Ceftizoxime: a third-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.
- 1 June 1990
- journal article
- review article
- Vol. 142 (11) , 1209-12
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1988
- Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: Comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedureDiagnostic Microbiology and Infectious Disease, 1987
- Cephalosporin, Carbapenem, and Monobactam AntibioticsMayo Clinic Proceedings, 1987
- Ceftizoxime plus ticarcillin: double β-lactam therapy for infections in cancer patientsJournal of Antimicrobial Chemotherapy, 1987
- Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patientsJournal of Antimicrobial Chemotherapy, 1987
- Antimicrobial Prophylaxis in SurgeryNew England Journal of Medicine, 1986
- Randomized comparative trial with ceftizoxime and cefotaxime in urinary tract infectionsInternational Urology and Nephrology, 1985
- Ceftizoxime A Review of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic UseDrugs, 1985
- Prospective, Randomized, Comparative Trials in the Therapy for Intraabdominal and Female Genital Tract InfectionsClinical Infectious Diseases, 1984
- Treatment of bacterial meningitis with ceftizoximeAntimicrobial Agents and Chemotherapy, 1984